Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank29
3Y CAGR-10.2%
5Y CAGR-6.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-10.2%/yr
vs +62.8%/yr prior
5Y CAGR
-6.2%/yr
Recent deceleration
Acceleration
-73.0pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $42.10M | -32.2% |
| 2023 | $62.10M | -3.9% |
| 2022 | $64.64M | +11.3% |
| 2021 | $58.07M | +14.5% |
| 2020 | $50.71M | -12.4% |
| 2019 | $57.88M | +143.0% |
| 2018 | $23.82M | +188.1% |
| 2017 | $8.27M | - |